THZ1, a covalent CDK7 inhibitor, enhances gemcitabine-induced cytotoxicity via suppression of Bcl-2 in urothelial carcinoma.

Kuan-Lin Kuo(National Taiwan University), Kuo‐How Huang(National Taiwan University), Zuo-He Wang(National Taiwan University Hospital), Wei‐Chou Lin(National Taiwan University), Shing‐Hwa Liu(National Taiwan University), Fu-Shun Hsu(National Taiwan University), Yu Cheng Kuo(National Taiwan University), Chen-Hsun Hsu(National Taiwan University Hospital), Shih-Ming Liao(National Taiwan University Hospital), Shao-Ping Yang(National Taiwan University Hospital)
PubMed
January 1, 2021
Cited by 6


Related Papers